13F filer · CIK 1067983 ↗
Berkshire Hathaway
You are looking at Q2 2021. See the latest, Q2 2026 →
Reported value
$293.02B
+8.4% on the quarter before
Positions
44
1 new · 3 sold out
Top 10
87.5%
of the value
Est. gain
+$24.71B
on stocks held all quarter
Est. return
+9.2%
on those stocks since Q1 2021
Positions as of Jun 30, 2021, from Berkshire Hathaway's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q1 2021. Striped tiles are options.
Largest buys
Since Q1 2021, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Kroger Co~$411.0MAdded · 0.7% → 0.8%+10,727,614 shares
- Aon Plc~$71.6MAdded · 0.3% → 0.4%+299,854 shares
- Organon & Co~$46.9MNew · 0.0% → 0.0%+1,550,481 shares
- Rh~$24.1MAdded · 0.4% → 0.4%+35,519 shares
Largest sells
Since Q1 2021, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Merck & Co. Inc~$678.6MCut · 0.5% → 0.2%−8,725,196 shares
- General Mtrs Co~$414.2MCut · 1.4% → 1.2%−7,000,000 shares
- Axalta Coating Sys Ltd~$410.8MSold out · 0.2% → 0.0%−13,887,037 shares
- Bristol-Myers Squibb Co~$316.6MCut · 0.7% → 0.6%−4,737,961 shares
- Abbvie Inc~$263.6MCut · 0.9% → 0.8%−2,340,317 shares
- Biogen Inc~$179.9MSold out · 0.1% → 0.0%−643,022 shares
- Marsh & Mclennan Cos Inc~$153.5MCut · 0.2% → 0.2%−1,090,834 shares
- Liberty Global Plc~$147.9MCut · 0.1% → 0.0%−5,470,446 shares
- Liberty Global Plc~$86.2MSold out · 0.0% → 0.0%−3,359,831 shares
- Chevron Corp New~$57.4MCut · 0.9% → 0.8%−548,351 shares
Holdings
As of Jun 30, 2021. Changes are in shares against Mar 31, 2021, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AppleCOM · shares 0% · price +12.1% | 41.5% | $121.50B | +$13.14B | ||||||||
| Bank Amer CorpCOM · shares 0% · price +6.6% | 14.2% | $41.65B | +$2.57B | ||||||||
| American Express CoCOM · shares 0% · price +16.8% | 8.5% | $25.05B | +$3.61B | ||||||||
| Coca Cola CoCOM · shares 0% · price +2.7% | 7.4% | $21.64B | +$560.0M | ||||||||
| Kraft Heinz CoCOM · shares 0% · price +1.9% | 4.5% | $13.28B | +$254.0M | ||||||||
| Moody's CorporationCOM · shares 0% · price +21.4% | 3.1% | $8.94B | +$1.57B | ||||||||
| Verizon Communications IncCOM · shares 0% · price −3.6% | 3.0% | $8.90B | −$336.7M | ||||||||
| Us Bancorp DelCOM NEW · shares −0.6% · price +3.0% | 2.5% | $7.34B | +$214.0M | ||||||||
| Davita IncCOM · shares 0% · price +11.7% | 1.5% | $4.35B | +$457.0M | ||||||||
| Charter Communications Inc NCL A · shares 0% · price +16.9% | 1.3% | $3.76B | +$544.4M | ||||||||
| Bank Of New York Mellon CorpCOM · shares 0% · price +8.3% | 1.3% | $3.71B | +$285.1M | ||||||||
| General Mtrs CoCOM · shares −10% · price +3.0% | 1.2% | $3.55B | +$102.6M | ||||||||
| Verisign IncCOM · shares 0% · price +14.6% | 1.00% | $2.92B | +$370.8M | ||||||||
| Chevron Corp NewCOM · shares −2.3% · price −0.0% | 0.83% | $2.42B | −$1.2M | ||||||||
| Kroger CoCOM · shares +21% · price +6.4% | 0.81% | $2.37B | +$118.5M | ||||||||
| Visa Inc.COM CL A · shares 0% · price +10.4% | 0.80% | $2.34B | +$220.6M | ||||||||
| Abbvie IncCOM · shares −10% · price +4.1% | 0.79% | $2.31B | +$90.7M | ||||||||
| Liberty Media Corp DelawareCOM C SIRIUSXM · shares 0% · price +5.2% | 0.68% | $2.00B | +$98.5M | ||||||||
| AmazonCOM · shares 0% · price +11.2% | 0.63% | $1.83B | +$184.6M | ||||||||
| Bristol-Myers Squibb CoCOM · shares −15% · price +5.8% | 0.60% | $1.76B | +$97.0M | ||||||||
| MastercardCL A · shares 0% · price +2.5% | 0.57% | $1.67B | +$41.3M | ||||||||
| SnowflakeCL A · shares 0% · price +5.5% | 0.51% | $1.48B | +$76.7M | ||||||||
| RhCOM · shares +2.0% · price +13.8% | 0.42% | $1.22B | +$144.7M | ||||||||
| Aon PlcSHS CL A · shares +7.3% · price +3.8% | 0.36% | $1.05B | +$35.4M | ||||||||
| Store Cap CorpCOM · shares 0% · price +3.0% | 0.29% | $842.6M | +$24.7M | ||||||||
| Total · 44 positions | 100% | $293.02B | +$24.71B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2021 to Q2 2021: 43 stocks held throughout, up $24.71B (+9.2%).
- Apple+$13.14B+12%
- American Express Co+$3.61B+17%
- Bank Amer Corp+$2.57B+7%
- Moody's Corporation+$1.57B+21%
- Coca Cola Co+$560.0M+3%
- Procter & Gamble Co−$158,000−0%
- Chevron Corp New−$1.2M−0%
- Globe Life Inc−$8.8M−1%
- Teva Pharmaceutical Inds Ltd−$70.2M−14%
- Verizon Communications Inc−$336.7M−4%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $299.25B+14% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $263.10B−4% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $274.16B+3% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $267.33B+4% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $257.52B−1% | SEC ↗ |
| Q1 2025 | May 15, 2025 (amended) | $259.81B−3% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $267.18B+0% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $266.38B−5% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $279.97B−16% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $331.68B−6% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 (amended) | $351.90B+12% | SEC ↗ |
| Q3 2023 | Nov 16, 2023 (amended) | $313.26B−10% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $348.19B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $325.11B+9% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $299.01B+1% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $296.10B−1% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $300.13B−17% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $363.55B+10% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $330.95B+13% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $293.45B+0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $293.02B+8% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $270.44B+0% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $269.93B+14% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 (amended) | $235.94B+17% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $202.41B+15% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $175.53B−27% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $242.05B+13% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $214.67B+3% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $208.10B+4% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $199.48B+9% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $183.07B−17% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $221.02B+13% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $195.62B+4% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $188.94B−1% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $191.24B+8% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $177.68B+10% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $162.14B+0% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $161.87B+9% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $147.99B+15% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $128.79B−1% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $129.70B+1% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $128.57B | SEC ↗ |